Biovations, LLC

biovations™ is dedicated to developing innovative and novel devices, biotechnologies, systems and processes using scientific advances in bioengineering, and the biological and medical sciences for applications in medicine and healthcare. biovations™ has developed a platform microfluidic technology for wide-spread, point-of-care, genetic mutation detection with applications in numerous markets. genetic mutations are the most abundant class of polymorphism and predispose individuals to specific diseases and influence their response to drugs. genetic testing identifies individuals who have predisposition to diseases before the onset of the symptoms. wide-spread screening of the population for genetic mutations will dramatically decrease healthcare costs and produce significant positive social impact by enabling the early detection of inherited disease, more effective and timely treatment, and lower mortality and morbidity among the population. biovations™, technology offers the potential